Loading insider details...
Beta
Latest Form 4 (Oct 8, 2026): Grant/Award of 3,796 HALO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 8, 2026 | HALOZYME THERAPEUTICS, INC. (HALO) | Grant/Award | 3,796 | n/a |
| Aug 11, 2026 | HALOZYME THERAPEUTICS, INC. (HALO) | Sale | 1,626 | $167.2K |
| Jul 2, 2026 | HALOZYME THERAPEUTICS, INC. (HALO) | Sale | 1,000 | $76.4K |
| Jun 22, 2026 | Editas Medicine, Inc. (EDIT) | Grant/Award | 51,700 | n/a |
| Jun 2, 2026 | HALOZYME THERAPEUTICS, INC. (HALO) | Sale | 1,625 | $107.6K |
| May 5, 2026 | HALOZYME THERAPEUTICS, INC. (HALO) | Sale | 1,625 | $103.2K |
| Jan 6, 2026 | HALOZYME THERAPEUTICS, INC. (HALO) | Sale | 2,000 | $140.5K |
| Dec 2, 2025 | HALOZYME THERAPEUTICS, INC. (HALO) | Sale | 829 | $59.4K |
| Nov 12, 2025 | HALOZYME THERAPEUTICS, INC. (HALO) | Sale | 2,000 | $137.0K |
| Oct 1, 2025 | HALOZYME THERAPEUTICS, INC. (HALO) | Sale | 1,500 | $112.6K |